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Cleaning validation is one of recommendation from Pharma-
ceutical Inspection Co-operation Scheme (PIC/S) to avoid
contamination of pharmaceutical products. The objective of
cleaning validation is to confirm reliability of cleaning proce-
dure for removal of contaminants associated with previous
products, residues of cleaning agents and potential microbial
contaminants [1]. Japanese Encephalitis vaccine is a new
product that is prequalified by World Health Organization
(WHO) and manufactured at GPO-MBP. Magnetic bar is dedi-
cated for this product and used in stainless steel vessel,
which is used for blending and filling processes of the final
bulk product.
To validate the cleaning procedure for themagnetic bar, rinse
sampling was applied.Total organic carbon (TOC) was used to
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detect product residue in rinsing solution. Correlation between
TOC and diluted vaccine (vaccine and water for injection (WFI)
ratio = 9:1 (v/v)) can be expressed with a linear equation;
y = 40.589× – 0.322. Coefficient of determination (r2) is 0.9993.
Recovery of the sampling technique is 92.7 ± 9.45%. Accep-
tance criteria for the product residue was defined based on no
more than 0.1% of the normal therapeutic dose of the product
that will appear in the maximum daily dose of the product.
Maximum residue of the previous product should notmore than
3.7 μl/ml of rinsing solution.TOC values of rinsing solution from
cleaning validation of magnetic bar were less than those of the
positive control, and conformed to the acceptance criteria. In
conclusion, cleaning procedure according to standard operat-
ing procedure of GPO-MBP is validated.
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Fig. 1 (A) Magnetic bar; (B) Correlation between TOC and product content.
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